Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
303.1 Understanding the experience of people living with amyotrophic lateral sclerosis: a qualitative study and conceptual model informed by patients, caregivers, and clinicians William Nowell 1 , Nadine McGale 2 , Oren Levy 1 , Sarah Wilding 2 , Phoebe Heinrich 2 , Nick Patel 1 , Jinsy Andrews 3 , Diana Rofail 1 1 Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA, 2 Modus Outcomes, Cambridge, Massachusetts, USA, 3 Department of Neurology, Colombia University, New York, USA Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :303.1 Aims This qualitative study aimed to (1) explore the experience of living with amyotrophic lateral sclerosis (ALS) through interviews with patients, caregivers, and clinicians, and (2) develop a conceptual model for this rare, progressive disease
In the EXSCEL CVOT trial, 8.7% of participants randomized to exenatide once weekly were also started on an SGLT2i
%25201.png)
The results were definitive: daily consumption successfully increased systemic body stores of glutathione
10.1159/000521273 [DOI] [PubMed] [Google Scholar] 143.Kasahara, K
The president confirmed that all Americans will be able to purchase "dozens" of the "most commonly used prescription drugs" through the portal
doi:10.2165/00129784-200404050-00002
